Bibliography
- Allarakhia M, Kilgour DM, Fuller D. Modeling the incentive to participate in open source biopharmaceutical innovation. R&D Management 2010;40:50-66
- Allarakhia M. Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases. Drug Des Devel Ther 2013;7:753-66
- Gao Z, Li H, Zhang H, et al. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 2008;9:104
- Günther S, Kuhn M, Dunkel M, et al. SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 2008;36(Database issue):D919-22
- Knox C, Law V, Jewison T, et al. DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res 2011;39(Database issue):D1035-41
- Taboureau O, Nielsen SK, Audouze K, et al. ChemProt; a disease chemical biology database. Nucleic Acids Res 2011;39(Database issue):D367-72
- Available from: openbabel.org [Accessed January 29 2014]
- Available from: www.thesgc.org [Accessed January 2014]
- Bayer HealthCare to Join Not-For-Profit SGC to Accelerate Research in Epigenetics. Bayer. 2013. Available from: http://www.newswire.ca/en/story/1281679/bayer-healthcare-to-join-not-for-profit-structural-genomics-consortium-to-accelerate-research-in-epigenetics [Last accessed January 2014]
- Available from: www.pistoiaalliance.org [Accessed January 2014]
- Available from: www.openphacts.org [Accessed January 2014]
- Hunter J, Stephens S. Is open innovation the way forward for big pharma? Nat Rev Drug Discov 2010;9:87-8
- Available from: openinnovation.lilly.com [Accessed January 2014]
- Available from: http://sagebase.org/tag/arch2pocm/ [Accessed January 2014]
- Masum H. Insider Views of Collaborative R&D for Health: Q&A with Aled Edwards. Center for Global Health Policy R&D Assessment. 2012. Available from: http://healthresearchpolicy.org/blog/2012/nov/1/insider-views-collaborative-rd-health-qa-aled-edwards [Accessed January 2014]
- Niesen P, Rockhold F. Access to patient-level data from Glaxosmithkline clinical trials. N Engl J Med 2013;369:475-8
- Available from: sagebase.org/synapse [Accessed January 2014]
- Reichman JH, Uhlir PF. A contractually reconstructed research commons for scientific data: international considerations. In: Essanu JM, Uhlir PF, editors, Open access and the public domain in digital data and information for science: proceedings of an international symposium. National Academics Press, Washington; 2004. p. 98-102
- Available from: www.osdd.net [Accessed January 2014]